Status:
COMPLETED
Echocardiography-guided Oval-shaped ASD Closure
Lead Sponsor:
National Cardiovascular Center Harapan Kita Hospital Indonesia
Conditions:
ASD II
Percutaneous Closure
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: An atrial septal defect (ASD) is considered oval-shaped when its shortest diameter is less than 75% of its longest diameter. Research on the percutaneous closure of oval-shaped ASDs is lim...
Detailed Description
Background: An atrial septal defect (ASD) is considered oval-shaped when its shortest diameter is less than 75% of its longest diameter. Research on the percutaneous closure of oval-shaped ASDs is lim...
Eligibility Criteria
Inclusion
- Oval-shaped secundum ASD with evidence of right ventricular overload, no significant and irreversible pulmonary arterial hypertension, no significant arrhythmia, no serious problems in other organs, and presumption of appropriate rims for device implantation
Exclusion
- Other than stated in inclusion criteria
Key Trial Info
Start Date :
July 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT06526403
Start Date
July 14 2018
End Date
May 30 2023
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cardiovascular Center Harapan Kita
Jakarta, Indonesia, 11420